ctrl K

Watchlist Price Alert

Annovis Bio Inc. (ANVS)

NYSE: ANVS · Real-Time Price · USD

2.64

-0.19 (-6.71%)

At close: Jun 17, 2025, 3:59 PM

2.69

1.89%

After-hours: Jun 17, 2025, 04:22 PM EDT

Annovis Bio Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-26.7M	-45.03M	-25.51M	-14.54M	-6.64M	-1.61M	-714K	-682K
Interest Income	331.85K	667.9M	182.71K	13.34K	47.23K	n/a	n/a	n/a
Pretax Income	-24.59B	-56.2M	-25.33M	-14.49M	-5.46M	-991K	-714K	-682K
Net Income	-24.59B	-56.2M	-25.33M	-14.49M	-5.46M	-991K	-714K	-682K
Selling & General & Admin	6.7M	6.24M	9M	6.06M	3.59M	829.37K	602.33K	409.06K
Research & Development	20M	38.79M	16.52M	8.48M	3.05M	776.26K	111.61K	273.37K
Other Expenses	n/a	n/a	n/a	-36.75K	-1.16M	-735K	n/a	n/a
Operating Expenses	26.7M	45.03M	25.51M	14.5M	6.64M	1.61M	713.94K	682.43K
Interest Expense	n/a	n/a	n/a	n/a	47.23M	n/a	66.00	84.00
Selling & Marketing Expenses	100K	100K	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	26.7M	45.03M	25.51M	14.5M	6.64M	1.61M	713.94K	682.43K
Income Tax Expense	-24.57B	n/a	-183K	-50.09K	-1.21M	-694K	-132	-682K
Shares Outstanding (Basic)	12.18M	9.02M	8.16M	7.63M	6.31M	6.84M	4.4M	4.39M
Shares Outstanding (Diluted)	12.23M	9.02M	8.16M	7.63M	6.31M	6.84M	4.4M	4.39M
EPS (Basic)	-2.02K	-6.23	-3.1	-1.9	-0.87	-0.17	-0.16	-0.16
EPS (Diluted)	-2.01K	-6.23	-3.1	-1.9	-0.87	-0.17	-0.16	-0.16
EBITDA	-22.74M	-45.03M	-25.51M	-14.5M	-5.46M	-791K	66.00	84.00
EBIT	-22.74M	-45.03M	-25.33M	-14.49M	-5.46M	-1.61M	-714K	-682K
Depreciation & Amortization	n/a	n/a	25.51M	14.54M	6.64M	1.61M	713.94K	682.43K